Untransfected HEK293 cells (green line) and transfected Human DLL3 HEK293 stable cells (red line) were stained with anti-DLL3 antibody (rovalpituzumab-like) (2µl/1*106cells), washed and then followed by FITC-conjugated anti-Human IgG1 Fc antibody and analyzed with flow cytometry.
The Binding Activity of DLL3 with Anti-DLL3 Recombinant Antibody.; ,Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 µg/mL can bind Anti-DLL3 Recombinant Antibody(RAC07055), the EC50 is 1.625-2.702 ng/mL.
The Binding Activity of DLL3 with Anti-DLL3 Recombinant Antibody.; , Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 µg/mL can bind Anti-DLL3 Recombinant Antibody(RAC07055), the EC50 is 1.102-1.707 ng/mL.